Search results for the

We have made some important changes to our requirements and processes for international applications to our Register.

We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).

We recognise that, due to unavoidable circumstances, some registrants may need to defer (put off) their audit.

This year, we launched a new Corporate Strategy and a commitment to meet our values to be fair, compassionate, inclusive and enterprising.

We will be asking you to ask you to complete an equality monitoring form to help us make sure our services are accessible to everyone

This policy statement sets out our broad approach to developing memorandums of understanding (MoUs) with other organisations.